0001213900-23-006044.txt : 20230130
0001213900-23-006044.hdr.sgml : 20230130
20230130165223
ACCESSION NUMBER: 0001213900-23-006044
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230130
FILED AS OF DATE: 20230130
DATE AS OF CHANGE: 20230130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fabbio Patrick
CENTRAL INDEX KEY: 0001658859
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36694
FILM NUMBER: 23568585
MAIL ADDRESS:
STREET 1: 2 PITNEY COURT
CITY: BASKING RIDGE
STATE: NJ
ZIP: 07920
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Protara Therapeutics, Inc.
CENTRAL INDEX KEY: 0001359931
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 204580525
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 345 PARK AVENUE SOUTH
STREET 2: 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10010
BUSINESS PHONE: 646-844-0337
MAIL ADDRESS:
STREET 1: 345 PARK AVENUE SOUTH
STREET 2: 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10010
FORMER COMPANY:
FORMER CONFORMED NAME: ArTara Therapeutics, Inc.
DATE OF NAME CHANGE: 20200110
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEON THERAPEUTICS INC
DATE OF NAME CHANGE: 20060420
4
1
ownership.xml
X0306
4
2023-01-30
0
0001359931
Protara Therapeutics, Inc.
TARA
0001658859
Fabbio Patrick
C/O PROTARA THERAPEUTICS, INC.
345 PARK AVENUE SOUTH, 3RD FLOOR
NEW YORK
NY
10010
0
1
0
0
Chief Financial Officer
Stock Option (Right to Buy)
3.14
2023-01-30
4
A
0
300000
0.00
A
2033-01-29
Common Stock
300000
300000
D
One-fourth of the shares shall vest on January 30, 2024 and the remainder of the shares will vest in a series of thirty-six successive equal monthly installments measured from January 30, 2024, subject to the Reporting Person's Continuous Service (as defined in the Company's 2020 Inducement Plan) with the Issuer through each such vesting date.
/s/ Mary Grendell, Attorney-in-Fact
2023-01-30